Franc Llorens Selected Research

Franc Llorens Research Topics

Disease

32	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 10/2013
23	Dementia (Dementias) 05/2022 - 08/2015
21	Sporadic Creutzfeldt-Jakob Disease 09/2022 - 01/2014
20	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 09/2013
15	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2007
11	Parkinson Disease (Parkinson's Disease) 05/2022 - 11/2014
11	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 09/2013
9	Disease Progression 05/2022 - 05/2015
9	Scrapie 04/2020 - 02/2014
8	Synucleinopathies 01/2022 - 01/2016
7	Fatal Familial Insomnia 01/2022 - 01/2016
5	Infections 12/2020 - 02/2014
5	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2020 - 09/2015
4	Cognitive Dysfunction 05/2022 - 03/2016
4	Neoplasms (Cancer) 11/2021 - 06/2011
3	Frontotemporal Dementia (Semantic Dementia) 11/2020 - 03/2016
3	Proteostasis Deficiencies 09/2018 - 01/2016
3	Tauopathies 01/2018 - 01/2016
3	Inflammation (Inflammations) 01/2018 - 01/2017
2	Acquired CJD 12/2020 - 08/2015
2	Neuroinflammatory Diseases 11/2019 - 11/2014
2	Pathologic Processes 09/2018 - 03/2016
2	Brain Diseases (Brain Disorder) 03/2016 - 09/2015
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2016 - 09/2013
2	Seizures (Absence Seizure) 07/2015 - 09/2011
1	Mixed Dementias 01/2022
1	Mesothelioma 11/2021
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 11/2021
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Metabolic Diseases (Metabolic Disease) 12/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2020
1	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 11/2020
1	Multiple Sclerosis 11/2020
1	Nervous System Diseases (Neurological Disorders) 08/2020
1	Neuroblastoma 04/2020
1	Cerebrovascular Trauma 01/2020
1	Gliosis 01/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Essential Tremor (Essential Tremors) 11/2016

Drug/Important Bio-Agent (IBA)

36	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2015
22	Prion ProteinsIBA 01/2022 - 09/2013
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
13	SynucleinsIBA 05/2022 - 11/2014
13	PrionsIBA 01/2022 - 02/2014
6	Codon (Codons)IBA 01/2022 - 05/2015
4	tau Proteins (tau Protein)IBA 01/2022 - 10/2015
4	Messenger RNA (mRNA)IBA 12/2020 - 09/2013
4	EnzymesIBA 01/2020 - 11/2016
4	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2010
4	CytokinesIBA 02/2016 - 01/2014
3	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2017
3	Protein AggregatesIBA 01/2018 - 02/2016
3	Amyloid (Amyloid Fibrils)IBA 10/2017 - 10/2015
2	Lipocalin-2IBA 01/2022 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2021
2	Chitinase-3-Like Protein 1IBA 01/2022 - 01/2018
2	alpha-SynucleinIBA 01/2021 - 01/2019
2	Peptides (Polypeptides)IBA 08/2020 - 12/2019
2	Mitochondrial DNA (mtDNA)IBA 08/2020 - 01/2016
2	NeurograninIBA 05/2020 - 01/2019
2	14-3-3 Proteins (14-3-3 Protein)IBA 02/2020 - 05/2016
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2017
2	ImmunosorbentsIBA 01/2020 - 11/2019
2	Reelin ProteinIBA 01/2020 - 10/2017
2	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 11/2019 - 11/2016
2	purineIBA 01/2017 - 01/2016
2	Methionine (L-Methionine)FDA Link 01/2017 - 01/2016
2	Epidermal Growth Factor (EGF)IBA 06/2013 - 06/2011
1	Calcium-Binding ProteinsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	amyloid beta-protein (1-42)IBA 01/2022
1	lipoarabinomannan (LAM)IBA 11/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	LigandsIBA 11/2020
1	ChemokinesIBA 11/2020
1	Amyloid beta-PeptidesIBA 08/2020
1	SPADIBA 08/2020
1	poly(propyleneimine)IBA 04/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Endopeptidase K (Proteinase K)IBA 10/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2018
1	neurofilament protein LIBA 01/2018
1	ChitinasesIBA 11/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2017
1	CalpainIBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	Odorant Receptors (Odorant Receptor)IBA 01/2017
1	CathepsinsIBA 01/2017
1	CalciumIBA 01/2017
1	ProteomeIBA 01/2017
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2017
1	Hazardous Substances (Hazardous Materials)IBA 11/2016

Therapy/Procedure

4	Therapeutics 12/2019 - 10/2009